Industry Satellite Symposia
Switch To Module
ESMO Congress 2022 - Conference Calendar
e-Posters
Industry Satellite Symposia
Everything
Everything
Session Title
Session Number
Presentation Title
Presentation Number
Author
Presenter
Chair
Filter By
Day
Select All
Deselect All
Fri, 09.09.2022
12
Sat, 10.09.2022
17
Sun, 11.09.2022
17
Mon, 12.09.2022
17
Room
Select All
Deselect All
7.1.D - Dijon Auditorium
8
7.2.E - Évry Auditorium
2
7.2.F - Fécamp Auditorium
6
7.3.G - Grenoble Auditorium
8
7.3.H - Honfleur Auditorium
7
7.3.O - Orléans Auditorium
6
7.3.Q - Quimper Auditorium
8
7.3.S - Strasbourg Auditorium
6
7.3.T - Toulouse Auditorium
6
7.3.U - Urval Auditorium
6
Session Type
Select All
Deselect All
EONS Industry Satellite Symposium
6
Industry Satellite Symposium
57
Presentation Type
Select All
Deselect All
Invited Speaker
1
Satellite Speaker
63
Presentation Topic
Select All
Deselect All
General interest
63
Cancel
Clear
Search
Advanced Search
Calendar view
All Sessions
All Presentations
Final Programme (PDF)
Industry Satellite Symposia
Browsing Over 63 Sessions
Sort By
Upcoming First
Upcoming First
Relevance
Session Number
Session Datetime
Mirati Therapeutics, Inc. - Advancing Tailored Therapies in NSCLC and KRASG12C-Driven Tumors
(ID 85)
Time
10:15 - 11:45
Bristol Myers Squibb - GI Cancer and Immuno-Oncology Today: Best Practice and Clinical Challenges
(ID 89)
Time
10:15 - 11:45
Deciphera Pharmaceuticals - From clinical trial to clinical practice: novel strategies for treating patients with advanced GIST
(ID 86)
Time
10:15 - 11:45
ACE Oncology - Navigating Treatment Decisions in Advanced NSCLC: Update on Molecular Testing and New Targeted Treatment Options
(ID 90)
Time
10:15 - 11:45
Novartis - Guiding Through Oesophageal Cancer: Expert Insights on the Patient Journey From Diagnosis to Treatment
(ID 87)
Time
10:15 - 11:45
PeerView Oncology - Targeting HER2-Low Expression in Breast Cancer: Evaluating the Evidence, Challenges, and Opportunities for Expanding Treatment Benefit to More Patients
(ID 88)
Time
10:15 - 11:45
PeerView Oncology - SERDs at the Inflection Point in Pretreated ER+/HER2- Breast Cancer: Addressing Unmet Needs, Establishing New Standards of Care, and Improving Patient Outcomes With Novel ER-Targeting Therapies
(ID 93)
Time
18:00 - 19:30
F. Hoffman-La Roche LTD - Navigating the possibilities of personalised healthcare in oncology
(ID 94)
Time
18:00 - 19:30
Gilead and Kite Oncology - CAR T-cell therapy: The next frontier in immuno-oncology
(ID 91)
Time
18:00 - 19:30
Janssen-Cilag International NV - Catching it early, getting it right: optimal disease and patient management from biomarkers to treatment selection for bladder cancer
(ID 95)
Time
18:00 - 19:30
Servier - Interpreting real-world data to better manage patients with metastatic colorectal cancer
(ID 92)
Time
18:00 - 19:30
Merck - From complex to simple: The journey to strategic sequencing in the management of mCRC
(ID 96)
Time
18:00 - 19:30